Institutional investors purchased a net $286.9 thousand shares of NXTM during the quarter ended December 2012, and now own 83.72% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
| Other institutional | 50.34% |
| Mutual fund holders | 33.38% |
| Individual stakeholders | 31.06% |